Avanços e desafios da política nacional de gestão de tecnologias em saúde

Silva, Hudson Pacífico da; Petramale, Clarice Alegre; Elias, Flávia Tavares Silva

doi:10.1590/s0034-89102012005000060

Cited by 35 publications

(29 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…While this one presented decisions for 224 processes between 2006 and 2011 (Silva, Petramale, Elias, 2012), that one has already completed 359 demands from 2012 to July 2015 (CONITEC, 2015).…”

Section: 8mentioning

confidence: 99%

“…From 2006 to 2011, CITEC received 351 proposals for incorporation, exclusion or alteration of health technologies, incorporating 85 technologies, not incorporating 65, excluding eight, not excluding two, filing four requests, extinguishing seven for being outside its scope and, also, preparing and reviewing 95 clinical protocols and therapeutic guidelines (Silva, Petramale, Elias, 2012).…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Evaluation of demands of inclusion, exclusion and alteration of technologies in the Brazilian Health System submitted to the National Committee on Technology Incorporation

Nunes

Fonteles

Passos

et al. 2017

Braz. J. Pharm. Sci.

View full text Add to dashboard Cite

The steady increase in the number of health technologies and advances in associated research generate management challenges in the choice of technologies to be made available to the public. From 2011, the process of inclusion, exclusion and alteration of technologies to the Brazilian Unified Health System (SUS) has undergone major transformations, such as the creation of the National Committee on Technology Incorporation (CONITEC). This study analyzed the decisions of CONITEC since its inception until July 2015. The analyzed variables were: type of technology, reason for application, name of the technology, indication, claimant and CONITEC decision status. We found that the Government was the main claimant, accounting for 58.1% of the 420 cases. The most frequent request was inclusion (93.8%) and the technology type was medicine (61.4%). Of the incorporated medicines, the classes of antineoplastic/immunomodulatory were the most frequent (39.47%). Society's desire for inclusion of an increasing amount of health technology contrasts with the limited resources available to management, which causes budget concerns. Using Health Technology Assessment (HTA), advances resulting from these innovations in the process were highlighted, and challenges were identified for the management and the academic community.

show abstract

Section: 8mentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Evaluation of demands of inclusion, exclusion and alteration of technologies in the Brazilian Health System submitted to the National Committee on Technology Incorporation

Nunes

Fonteles

Passos

et al. 2017

Braz. J. Pharm. Sci.

View full text Add to dashboard Cite

show abstract

“…Group 1 (red) includes health policy and analysis research such as policy design and implementation [48-50], challenges of health policy and health technology [51,52], health care system reforms and performance monitoring [53-56] (i.e., China), metropolitan and regional health planning [57], priority setting and agendas [58,59], policy of financial access and equity [48]. New health policies represent the efforts in introducing deliberate and purposeful changes within health systems.…”

Section: Resultsmentioning

confidence: 99%

Scientometric trends and knowledge maps of global health systems research

Yao

Chen

Yao

et al. 2014

Health Res Policy Sys

View full text Add to dashboard Cite

BackgroundIn the last few decades, health systems research (HSR) has garnered much attention with a rapid increase in the related literature. This study aims to review and evaluate the global progress in HSR and assess the current quantitative trends.MethodsBased on data from the Web of Science database, scientometric methods and knowledge visualization techniques were applied to evaluate global scientific production and develop trends of HSR from 1900 to 2012.ResultsHSR has increased rapidly over the past 20 years. Currently, there are 28,787 research articles published in 3,674 journals that are listed in 140 Web of Science subject categories. The research in this field has mainly focused on public, environmental and occupational health (6,178, 21.46%), health care sciences and services (5,840, 20.29%), and general and internal medicine (3,783, 13.14%). The top 10 journals had published 2,969 (10.31%) articles and received 5,229 local citations and 40,271 global citations. The top 20 authors together contributed 628 papers, which accounted for a 2.18% share in the cumulative worldwide publications. The most productive author was McKee, from the London School of Hygiene & Tropical Medicine, with 48 articles. In addition, USA and American institutions ranked the first in health system research productivity, with high citation times, followed by the UK and Canada.ConclusionsHSR is an interdisciplinary area. Organization for Economic Co-operation and Development countries showed they are the leading nations in HSR. Meanwhile, American and Canadian institutions and the World Health Organization play a dominant role in the production, collaboration, and citation of high quality articles. Moreover, health policy and analysis research, health systems and sub-systems research, healthcare and services research, health, epidemiology and economics of communicable and non-communicable diseases, primary care research, health economics and health costs, and pharmacy of hospital have been identified as the mainstream topics in HSR fields. These findings will provide evidence of the current status and trends in HSR all over the world, as well as clues to the impact of this popular topic; thus, helping scientific researchers and policy makers understand the panorama of HSR and predict the dynamic directions of research.

show abstract

“…Contudo, apesar dos bons resultados alcançados, ainda se observam limitações de natureza cultural e estrutural para o uso das avaliações econômicas, bem como gargalos relativos à falta de equipe técnica permanente e à rotatividade dos tomadores de decisão (Elias e Araújo, 2014). Silva et al (2012), em análise sobre os avanços e os desafios da Política Nacional de Gestão de Tecnologias em Saúde, destacam que as dificuldades dizem respeito ao fato de que as atividades de ATS ainda estão centralizadas no Ministério da Saúde; à baixa sustentabilidade das atividades de produção e disseminação das avaliações, que dependem muito das iniciativas daquele órgão; e à baixa integração da política de saúde com a política de ciência e tecnologia. Sobre o limite de custo--efetividade das tecnologias para o Brasil, Prado (2015) ressalta a importância de defini-lo, considerando-se questões relativas ao custo de oportunidade e à necessidade de elaborar um plano de desinvestimentos.…”

Section: Incentivo à Produção E Ao Uso De Evidências Econômicas Sob Aunclassified

Evidências econômicas de intervenções em saúde sob a perspectiva do sistema único de saúde: por que e para que produzi-las e utilizá-las?

Vieira¹

2017

JBES

View full text Add to dashboard Cite

RESUMOO Brasil vem promovendo avanços significativos desde os anos 1990 quanto à produção e ao uso de evidências econômicas na tomada de decisão sobre intervenções em saúde. Mas essa produção ainda é insuficiente para dar respostas a todas as questões formuladas no âmbito do sistema. Assim, o objetivo deste artigo é o de discutir as possibilidades de uso de evidências econômicas disponí-veis na literatura científica internacional na tomada de decisão no Sistema Único de Saúde (SUS) e a necessidade de produção e uso dessas evidências na tomada de decisão em saúde. Para tanto, revisão bibliográfica da literatura foi realizada com o propósito de identificar estudos que apresentem resultados relevantes para as questões analisadas neste trabalho. Sobre a transferibilidade de evidências econômicas produzidas em outros países para uso na tomada de decisão sobre intervenções no SUS, o que os achados da literatura revelam é que existem muitas limitações a esse respeito. Ademais, os métodos para adaptação de avaliações econômicas ainda são pouco discutidos. Com isso, tem-se que as possibilidades de uso de evidências econômicas obtidas da literatura internacional em decisões no âmbito do SUS são extremamente limitadas e, portanto, ao se reconhecer a relevância dessas evidências na tomada de decisão em saúde, chega-se à conclusão de que é preciso produzi-las usando dados e informações do SUS. ABSTRACTBrazil has been promoting significant advances since the 1990s regarding the production and use of economic evidence in decision-making on health interventions. But this production is still insufficient to provide answers to all the questions raised within the system. Thus, the objective of this article is to discuss the possibilities of using economic evidence available at international scientific literature in decision-making of the Brazilian Public Health System (SUS) and the need to produce and use this evidence in health decision-making. For this purpose, literature review was carried out to identify studies that present relevant results for the issues analyzed in this study. Regarding the transferability of economic evidence produced in other countries for use in decision-making on SUS interventions, there are many limitations. In addition, the discussion about methods for adapting economic evaluations isn't enough yet. Thus, the possibilities of using economic evidence obtained from the international literature in decisions of the SUS are extremely limited and, therefore, it is necessary to produce them using data and information from the SUS, once it is recognized the relevance of these evidences in the health decision-making.

show abstract

Avanços e desafios da política nacional de gestão de tecnologias em saúde

Cited by 35 publications

References 9 publications

Evaluation of demands of inclusion, exclusion and alteration of technologies in the Brazilian Health System submitted to the National Committee on Technology Incorporation

Evaluation of demands of inclusion, exclusion and alteration of technologies in the Brazilian Health System submitted to the National Committee on Technology Incorporation

Scientometric trends and knowledge maps of global health systems research

Evidências econômicas de intervenções em saúde sob a perspectiva do sistema único de saúde: por que e para que produzi-las e utilizá-las?

Contact Info

Product

Resources

About